Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Definition Profiling of Ovarian Cancer Ascites for the Identification of Prognostic Biomarkers and Immunotherapeutic Targets: an Integrative Cell of Origin-guided Approach

NCT06553742 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06553742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06553742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Definition Profiling of Ovarian Cancer Ascites for the Identification of Prognostic Biomarkers and Immunotherapeutic Targets: an Integrative Cell of Origin-guided Approach
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2024
Completion date
December 31, 2033
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascites, high grade ovarian serous adenocarcinoma, ovarian cancer